Tyrosine hydroxylase inhibitor
Tyrosine hydroxylase inhibitor - any substance that inhibits tyrosine 3 monooxygenase (tyrosine hydroxylase), an enzyme that catalyzes the conversion of tyrosine to dihydroxyphenylalanine, a precursor to dopamine, norepinephrine, and epinephrine. Inhibition of tyrosine hydroxylase can lead to a depletion of dopamine and norepinephrine in the brain.
Resources[edit source]
Latest articles - Tyrosine hydroxylase inhibitor
 | This medical article is a stub. You can help WikiMD by expanding it. |
Source: Data courtesy of the U.S. National Library of Medicine. Since the data might have changed, please query MeSH on Tyrosine hydroxylase inhibitor for any updates.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
